Are You a Good Candidate?
Share a few details and our clinical team will review your profile within 24–48 hours — completely confidential.
lock Your information is 100% private and used strictly for clinical assessment.
How Clinical Eligibility is Determined in India
In India, obesity and metabolic disease risk are evaluated using South Asian specific clinical guidelines established by the Endocrine Society of India (ESI) and RSSDI. South Asians naturally have higher visceral adiposity at lower body weights compared to Caucasian populations.
BMI ≥ 30.0 kg/m²
Qualifies for clinical obesity treatment and doctor-supervised medical evaluation.
BMI 27.0–30.0
Qualifies when accompanied by metabolic conditions like PCOS, Prediabetes, Fatty Liver, or Hypertension.
Doctor-Led Titration
Continuous clinical monitoring, lab tests, and personalized dose titration for sustainable fat loss.